We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HARP
3126
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$5.78M ﹤0.01%
39,069
+174
+0.4% +$26.4K
MCHX icon
3127
Marchex
MCHX
$79.3M
$5.77M ﹤0.01%
1,527,327
-4,009
-0.3% -$14.4K
BCEL
3128
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$5.77M ﹤0.01%
372,974
+2,525
+0.7% +$30.5K
ENZ
3129
DELISTED
Enzo Biochem, Inc.
ENZ
$5.68M ﹤0.01%
2,158,840
-4,192
-0.2% -$12.5K
BTAI icon
3130
BioXcel Therapeutics
BTAI
$27.1M
$5.66M ﹤0.01%
24,227
+285
+1% +$28.7K
PBIP
3131
DELISTED
Prudential Bancorp, Inc.
PBIP
$5.65M ﹤0.01%
304,751
+8,764
+3% +$155K
MBIO icon
3132
Mustang Bio
MBIO
$4.39M
$5.63M ﹤0.01%
1,841
-9
-0.5% -$20.6K
MRBK icon
3133
Meridian
MRBK
$236M
$5.58M ﹤0.01%
553,272
+273,000
+97% +$2.53M
PDLB icon
3134
Ponce Financial Group
PDLB
$484M
$5.58M ﹤0.01%
529,126
+63,140
+14% +$643K
PRTK
3135
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.56M ﹤0.01%
1,378,882
+31,045
+2% +$108K
ACNT icon
3136
Ascent Industries
ACNT
$140M
$5.53M ﹤0.01%
428,153
-815
-0.2% -$11.3K
ARAV
3137
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.52M ﹤0.01%
403,947
+278,252
+221% +$2.46M
AU icon
3138
AngloGold Ashanti
AU
$48.7B
$5.49M ﹤0.01%
245,518
-365,160
-60% -$7.35M
FFNW
3139
DELISTED
First Financial Northwest, Inc
FFNW
$5.48M ﹤0.01%
366,968
+506
+0.1% +$7.33K
ALOT icon
3140
AstroNova
ALOT
$226M
$5.47M ﹤0.01%
398,408
+52,288
+15% +$797K
FTR
3141
DELISTED
Frontier Communications Corp.
FTR
$5.46M ﹤0.01%
6,141,355
-2,405,625
-28% -$1.96M
HOOK
3142
DELISTED
HOOKIPA Pharma
HOOK
$5.44M ﹤0.01%
44,465
+31,326
+238% +$2.66M
ALBO
3143
DELISTED
Albireo Pharma Inc
ALBO
$5.44M ﹤0.01%
213,937
+7,123
+3% +$142K
CTSO icon
3144
Cytosorbents Corp
CTSO
$22.9M
$5.41M ﹤0.01%
1,404,466
-4,430
-0.3% -$19.3K
SEAC
3145
DELISTED
Seachange International Inc
SEAC
$5.4M ﹤0.01%
64,406
-11,221
-15% -$762K
MPX
3146
DELISTED
Marine Products Corp
MPX
$5.38M ﹤0.01%
373,974
-2,108
-0.6% -$30.5K
EVI icon
3147
EVI Industries
EVI
$182M
$5.37M ﹤0.01%
198,676
-648
-0.3% -$20.3K
KRMD icon
3148
KORU Medical Systems
KRMD
$167M
$5.37M ﹤0.01%
+821,633
New +$4.01M
SMTA
3149
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$5.28M ﹤0.01%
6,880,292
+1,206,431
+21% +$3.39M
BW icon
3150
Babcock & Wilcox
BW
$1.41B
$5.28M ﹤0.01%
1,450,119
-1,013
-0.1% -$3.96K

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.